To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Bentiromide
Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada (It was withdrawn in the US in October 1996.) Data
See also
|
||||||||||||||||||||||||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Bentiromide". A list of authors is available in Wikipedia. |
- Haplogroup_I1a_(Y-DNA)
- ProTec Polymer Processing GmbH begins operations
- Brückner Formtec sells CPP Extrusion Line for the Japanese Market
- Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover
- Making light work of emerging micropollutants - Dangerous and environmentally harmful organic micropollutants can be successfully removed from wastewater using high-intensity pulses of light